Vaginal/Vulvar Pruritus in a 52-Year-Old Woman

Clinical Profile Summary

Most Likely Diagnosis

Vulvar Lichen Sclerosus (LS) or Atrophic Vaginitis (Genitourinary Syndrome of Menopause — GSM)

Differential Diagnosis (Ranked by Likelihood)

1. 🥇 Lichen Sclerosus (Most Likely)

• Chronic inflammatory dermatosis of the vulva
• Classic presentation: intense pruritus, white parchment-like skin, figure-of-eight pattern around vulva and anus
• No vaginal discharge — because it is primarily a skin/dermal condition, not infectious
• Peak incidence in postmenopausal women
• Associated with autoimmune diseases (thyroid disease, vitiligo, alopecia areata)
• Risk of squamous cell carcinoma (~5%) if untreated

2. 🥈 Genitourinary Syndrome of Menopause (GSM) / Atrophic Vaginitis

• Due to estrogen deficiency → vaginal and vulvar atrophy
• Symptoms: dryness, itching, burning, dyspareunia
• Discharge absent or minimal
• No dysuria unless severe atrophy
• Very common at age 52

3. 🥉 Lichen Simplex Chronicus (LSC)

• Result of chronic scratch-itch cycle
• Thickened (lichenified), leathery vulvar skin
• Intense pruritus, worse at night
• Often secondary to another condition (LS, atrophy, contact dermatitis)

4. Contact/Allergic Dermatitis

• Reaction to soaps, detergents, sanitary products, spermicides
• Pruritus without primary discharge

5. Vulvovaginal Candidiasis (Less Likely)

• Typically presents with thick white curdlike discharge, external dysuria, and erythema
• Absence of discharge makes this less likely here
• Confirmed by wet mount (KOH prep showing hyphae/spores) and pH 4.0–4.5 (Management of Candidiasis, p. 36)

6. Diabetes Mellitus-related Pruritus

• Hyperglycemia predisposes to candidal overgrowth and nerve-mediated itch
• Must be excluded especially at this age

Investigations

Treatment

A. Lichen Sclerosus

• Clobetasol propionate 0.05% ointment — apply thinly to affected area OD for 3 months, then taper to maintenance (British Association of Dermatologists Guidelines 2018; Management of Vulval Conditions, p. 17)
• Alternative: Mometasone furoate 0.1% ointment
• Maintenance therapy long-term (LS does not cure, requires sustained control)
• Topical calcineurin inhibitors (tacrolimus 0.1%, pimecrolimus) — second-line, especially for steroid-resistant cases
• Regular follow-up every 6–12 months due to malignant transformation risk

B. Genitourinary Syndrome of Menopause (Atrophic Vaginitis)

• Local (topical) estrogen therapy — vaginal estradiol cream, pessary, or ring (safest; minimal systemic absorption)
  • Estriol cream applied vaginally 2–3x/week
• Non-hormonal: vaginal moisturizers (e.g., Replens) and lubricants for symptomatic relief
• Systemic HRT (oral/transdermal estrogen) if systemic menopausal symptoms also present; balance against individual risk profile (breast cancer, VTE)
• Ospemifene (SERM) — oral option for dyspareunia-predominant GSM

C. Lichen Simplex Chronicus

• Break the itch-scratch cycle
• Moderate-potency topical steroids (betamethasone valerate 0.1%)
• Oral antihistamines (hydroxyzine) at night for itch relief
• Silk/cotton underwear; avoid irritants (Management of Vulval Conditions, p. 17)

D. General/Supportive Measures (All Causes)

• Avoid soap, bubble baths, synthetic underwear
• Use fragrance-free emollients (aqueous cream, white soft paraffin)
• Cotton loose-fitting underwear
• Avoid over-washing
• Control blood glucose if diabetes identified

Summary Algorithm

52-yr-old woman, vulval pruritus, no discharge, no dysuria
           ↓
Examine vulva → white, atrophic, figure-of-8 patch?
    YES → Lichen Sclerosus → Biopsy → Clobetasol 0.05%
    NO  ↓
Postmenopausal signs? (vaginal dryness, atrophy)
    YES → GSM/Atrophic Vaginitis → Local estrogen
    NO  ↓
Lichenified/thickened skin?
    YES → Lichen Simplex Chronicus → Mid-potency steroid
    NO  ↓
Exclude Candida (KOH prep), Diabetes (HbA1c), Contact dermatitis (patch test)